Federal regulators on Thursday approved a new higher-dose version of the blockbuster obesity drug Wegovy that may help users ...

The high-dose Wegovy helped patients with obesity lose an average 20.7% of their weight after 72 weeks in a phase three trial.

When you buy through our links, Business Insider may earn an affiliate commission. Learn more Mornings move fast, and no one wants to wait their turn at the toaster. While our guide to the best ...

Common iron supplement side effects include gastrointestinal problems, decreased zinc absorption and interaction with certain ...

You’d be forgiven for thinking the MG4 Urban is a version of the MG4 aimed at buyers who mostly drive around town. Well, it isn’t – it’s actually a completely ...